NCT07518693

Brief Summary

This is a retrospective self-controlled observational study. We evaluated the safety and efficacy of a handmade frameless levonorgestrel-releasing intrauterine system (GyneFix-LNG-IUS) in patients at high risk of IUD expulsion. The device was constructed by combining the GyneFix IUD anchor system and a conventional LNG-IUS with the T-shaped arms removed. All data were collected from routine clinical records. The primary outcome was device expulsion or migration during follow-up.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

April 1, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 8, 2026

Completed
Last Updated

April 8, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

April 1, 2026

Last Update Submit

April 1, 2026

Conditions

Keywords

GyneFix-LNG-IUSFrameless LNG-IUSIUD expulsionAdenomyosisMenorrhagiaRetrospective study

Outcome Measures

Primary Outcomes (1)

  • IUD Expulsion Rate

    Rate of GyneFix-LNG-IUS expulsion during follow-up in high-risk patients with adenomyosis, uterine cavity enlargement, or cervical laxity.

    12 months post-insertion

Secondary Outcomes (1)

  • Clinical Efficacy

    12 months post-insertion

Study Arms (1)

High-Risk Patients with IUD Expulsion

Patients at high risk of IUD expulsion, including those with adenomyosis, uterine cavity enlargement, cervical laxity, or heavy menstrual bleeding, who received handmade frameless GyneFix-LNG-IUS placement.

Device: Handmade Frameless GyneFix-LNG-IUS

Interventions

A handmade frameless levonorgestrel-releasing intrauterine system, constructed by combining the GyneFix IUD anchor system and a conventional LNG-IUS with the T-shaped arms removed, for placement in high-risk patients to reduce IUD expulsion.

Also known as: GyneFix-LNG-IUS
High-Risk Patients with IUD Expulsion

Eligibility Criteria

Age25 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Female patients aged 25-55 years at high risk of intrauterine device (IUD) expulsion, including those with adenomyosis, uterine cavity enlargement, cervical laxity, or heavy menstrual bleeding, who received handmade frameless GyneFix-LNG-IUS placement at The Third People's Hospital of Bengbu.

You may qualify if:

  • Female patients aged 25-55 years
  • High risk of IUD expulsion, including adenomyosis, uterine cavity enlargement, cervical laxity, or heavy menstrual bleeding
  • Received handmade frameless GyneFix-LNG-IUS placement
  • Complete clinical follow-up data available

You may not qualify if:

  • Pregnancy or lactation
  • Severe systemic diseases
  • Contraindications for intrauterine device placement
  • Incomplete follow-up data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Third People's Hospital of Bengbu

Bengbu, Anhui, 233000, China

Location

MeSH Terms

Conditions

AdenomyosisEndometriosisMenorrhagiaDysmenorrheaMetrorrhagia

Condition Hierarchy (Ancestors)

Uterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesUterine HemorrhageHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsMenstruation DisturbancesPelvic PainPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Attending Physician, Department of Obstetrics and Gynecology

Study Record Dates

First Submitted

April 1, 2026

First Posted

April 8, 2026

Study Start

February 1, 2024

Primary Completion

October 31, 2024

Study Completion

October 31, 2024

Last Updated

April 8, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations